SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-035323
Filing Date
2020-11-05
Accepted
2020-11-05 16:48:49
Documents
15
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea129412-8k_cormedixinc.htm   iXBRL 8-K 33778
2 PRESS RELEASE DATED NOVEMBER 5, 2020 ea129412ex99-1_cormedixinc.htm EX-99.1 61715
3 GRAPHIC ex99-1_001.jpg GRAPHIC 20649
  Complete submission text file 0001213900-20-035323.txt   277652

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20201105.xsd EX-101.SCH 3433
5 XBRL DEFINITION FILE crmd-20201105_def.xml EX-101.DEF 11104
6 XBRL LABEL FILE crmd-20201105_lab.xml EX-101.LAB 22525
7 XBRL PRESENTATION FILE crmd-20201105_pre.xml EX-101.PRE 11507
8 EXTRACTED XBRL INSTANCE DOCUMENT ea129412-8k_cormedixinc_htm.xml XML 2568
Mailing Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922
Business Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 201291256
SIC: 2834 Pharmaceutical Preparations